Success Metrics

Clinical Success Rate
60.0%

Based on 3 completed trials

Completion Rate
60%(3/5)
Active Trials
0(0%)
Results Posted
100%(3 trials)
Terminated
2(40%)

Phase Distribution

Ph not_applicable
5
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(3)
Terminated(2)

Detailed Status

Completed3
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
60.0%
Most Advanced
N/A

Trials by Phase

N/A5 (100.0%)

Trials by Status

terminated240%
completed360%

Recent Activity

0 active trials
Showing 5 of 5
terminatednot_applicable

Examining the Effects of Neuromodulation on Glucose Metabolism in Type 2 Diabetes

NCT02130401
completednot_applicable

STEM-Parkinson's Disease

NCT04797611
terminatednot_applicable

A Pilot Study of a Non-Invasive Neuromodulation Device for Treatment of Parkinson's Disease

NCT02134795
completednot_applicable

Effects of Neuromodulation on Verbal Fluency in Post-stroke Aphasia

NCT02270866
completednot_applicable

Neurostimulation Device for Treatment of Migraine Headache

NCT01630044

Clinical Trials (5)

Showing 5 of 5 trials
NCT02130401Not Applicable

Examining the Effects of Neuromodulation on Glucose Metabolism in Type 2 Diabetes

Terminated
NCT04797611Not Applicable

STEM-Parkinson's Disease

Completed
NCT02134795Not Applicable

A Pilot Study of a Non-Invasive Neuromodulation Device for Treatment of Parkinson's Disease

Terminated
NCT02270866Not Applicable

Effects of Neuromodulation on Verbal Fluency in Post-stroke Aphasia

Completed
NCT01630044Not Applicable

Neurostimulation Device for Treatment of Migraine Headache

Completed

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5